Breakthrough for kinesiologists studying metabolic protein

May 1, 2018 by Lisa Owens Viani , San Francisco State University
Assistant Professor of Kinesiology Jimmy Bagley and Irene Tobias, a postdoctoral researcher at CSU Fullerton, analyze muscle fibers. Credit: Andy Galpin, CSU Fullerton

San Francisco State University researchers have discovered a new method for testing levels of a tiny but hugely important protein—"AMPK"—in human muscle cells. "AMPK is the gas gauge that tells each cell in your body if your fuel is too low. We call it the energy sensor of the cell," said Assistant Professor of Kinesiology Jimmy Bagley.

Muscles make up 30 to 40 percent of our bodies and are the largest users of sugar and fat for energy. But if people have too much stored fuel—if they are obese or not exercising, for example—AMPK is not activated and the body doesn't regulate blood sugar the way it should. Bagley and his colleagues at the Center for Sport Performance at CSU Fullerton are the first to test the new method on human muscle cells. Their innovative technique was just published in the Journal of Applied Physiology.

Using human muscle fiber samples provided by Stanford University and CSU Fullerton, researchers in Bagley's Muscle Physiology Laboratory manually isolate single muscle fibers, each about half the size of a human hair. With custom microscopes, tweezers and chemical solutions, they determine fiber type and prepare each cell for analysis. They then deliver the cells to CSU Fullerton, where the protein is analyzed using a new machine called Protein Simple. "We can tell what's happening with the AMPK protein in individual muscle cells with a high level of precision," said Bagley.

The new method allows researchers to isolate and examine muscle fibers in much greater detail than was possible before. "What people did in the past is take a muscle sample and grind it up—homogenize it—and then run an analysis on that big ground-up sample," said Bagley. "The problem with that is that fat cells, blood vessels, stem cells and other things get mixed in, meaning that there can be false positives or false negatives."

Until recently, diabetes researchers have focused on fat cells and in the pancreas and other organs. But muscles are the biggest sugar reservoir in the body, said Bagley. "We need to get diabetics' muscles to use more sugar, and activating AMPK is one of the steps that tells the muscle to do it." The kind of analysis his lab is performing could be used as part of a fitness and training program for pre-diabetics and others. Researchers could take muscle biopsies before and after a 12- to 16-week exercise regimen to see how the muscle fibers have adapted.

"We want to know at the cellular level—is this muscle fiber able to use glucose better?" said Bagley. "It then gives us ideas about how to treat that. It can probably be used to see if certain pharmaceuticals could affect the AMPK protein, as well."

Bagley currently shares the Protein Simple device with CSU Fullerton, but he is seeking funding for one that can be housed in the Muscle Physiology Laboratory. In the meantime, he says, this new method of analyzing AMPK "supports the ground level of molecular biology in the 21st century. Now we're going to keep stacking on top of it."

Explore further: Muscle regeneration compromises stability in muscular dystrophy

More information: Irene S. Tobias et al. Fiber type-specific analysis of AMPK isoforms in human skeletal muscle: advancement in methods via capillary nanoimmunoassay, Journal of Applied Physiology (2018). DOI: 10.1152/japplphysiol.00894.2017

Related Stories

Muscle regeneration compromises stability in muscular dystrophy

March 1, 2018
A new study finds that muscle fibers in Duchenne muscular dystrophy (DMD) split during regeneration to such an extreme that the muscle is weakened beyond repair. The article is published ahead of print in the American Journal ...

Researchers discover key to maintaining muscle strength while we age

June 2, 2015
What causes us to lose muscle strength as we age and how exercise can prevent it from happening has never been thoroughly understood, but McMaster University researchers have discovered a key protein required to maintain ...

Study identifies potential drug targets for muscular dystrophy treatments

January 9, 2017
Myotonic dystrophy type I (MD1) is a common form of muscular dystrophy associated with muscle wasting, weakness, and myotonia. These symptoms are linked to the accumulation of toxic gene transcripts in muscle cells that result ...

Researchers create skeletal muscle from stem cells

December 18, 2017
UCLA scientists have developed a new strategy to efficiently isolate, mature and transplant skeletal muscle cells created from human pluripotent stem cells, which can produce all cell types of the body. The findings are a ...

Muscular dystrophy clue

February 12, 2018
Patients with Duchenne muscular dystrophy (DMD) have a genetic mutation that causes incurable muscle degeneration. Research has shown that the immune system plays a complex, double-sided role in muscular dystrophy—promoting ...

Recommended for you

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Hybrid prevalence estimation: Method to improve intervention coverage estimations

December 6, 2018
LSTM's Professor Joseph Valadez is senior author on a new study published today in the Proceedings of the National Academy of Sciences, which outlines proposals for a more accurate estimator of health data.

World's smallest wearable device warns of UV exposure, enables precision phototherapy

December 5, 2018
The world's smallest wearable, battery-free device has been developed by Northwestern Medicine and Northwestern's McCormick School of Engineering scientists to measure exposure to light across multiple wavelengths, from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.